Application 021810
- Type
- BLA
- Sponsor
- NOVO NORDISK INC
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 021810 | Novolog Mix 50/50 | insulin aspart protamine and insulin aspart | 351(a) | Disc | 2026-08-01 |
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | NOVOLOG MIX 50/50 | INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT | INJECTABLE;SUBCUTANEOUS | 50 UNITS/ML;50 UNITS/ML | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.